Gordon P Otto

1.4k total citations
20 papers, 934 citations indexed

About

Gordon P Otto is a scholar working on Epidemiology, Immunology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Gordon P Otto has authored 20 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Immunology and 5 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Gordon P Otto's work include Sepsis Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). Gordon P Otto is often cited by papers focused on Sepsis Diagnosis and Treatment (8 papers), Neutropenia and Cancer Infections (4 papers) and Biosimilars and Bioanalytical Methods (4 papers). Gordon P Otto collaborates with scholars based in Germany, Switzerland and Japan. Gordon P Otto's co-authors include Ralf A. Claus, Maik Soßdorf, Michael Bauer, Jürgen Rödel, Konrad Reinhart, Katja Menge, Niels C. Riedemann, Wolfgang Lösche, Christoph Sponholz and Oliver Kurzai and has published in prestigious journals such as PLoS ONE, Medicine & Science in Sports & Exercise and Critical Care Medicine.

In The Last Decade

Gordon P Otto

20 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gordon P Otto Germany 12 365 362 200 165 95 20 934
Maik Soßdorf Germany 11 414 1.1× 371 1.0× 144 0.7× 173 1.0× 98 1.0× 22 922
Barbara Adamik Poland 18 174 0.5× 243 0.7× 198 1.0× 122 0.7× 129 1.4× 60 803
Sina M. Coldewey Germany 19 213 0.6× 229 0.6× 372 1.9× 94 0.6× 130 1.4× 57 1.0k
Taichin Koh Japan 17 266 0.7× 229 0.6× 358 1.8× 139 0.8× 106 1.1× 30 905
Renyu Ding China 16 159 0.4× 266 0.7× 206 1.0× 94 0.6× 114 1.2× 39 869
Hideo Hosotsubo Japan 21 348 1.0× 301 0.8× 357 1.8× 122 0.7× 180 1.9× 49 1.2k
K Inada Japan 21 437 1.2× 452 1.2× 247 1.2× 119 0.7× 167 1.8× 68 1.2k
Y Vrindts Belgium 7 402 1.1× 386 1.1× 249 1.2× 123 0.7× 151 1.6× 11 1.1k
Marisa Alegre Belgium 3 267 0.7× 390 1.1× 105 0.5× 131 0.8× 113 1.2× 3 752
Wolfgang Kox Germany 8 646 1.8× 528 1.5× 169 0.8× 208 1.3× 151 1.6× 13 1.2k

Countries citing papers authored by Gordon P Otto

Since Specialization
Citations

This map shows the geographic impact of Gordon P Otto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon P Otto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon P Otto more than expected).

Fields of papers citing papers by Gordon P Otto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon P Otto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon P Otto. The network helps show where Gordon P Otto may publish in the future.

Co-authorship network of co-authors of Gordon P Otto

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon P Otto. A scholar is included among the top collaborators of Gordon P Otto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon P Otto. Gordon P Otto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Harbeck, Nadia, et al.. (2019). Safety Analysis of Proposed Pegfilgrastim Biosimilar In Phase I And Phase Iii Studies. Future Oncology. 15(12). 1313–1322. 5 indexed citations
3.
Velinova, Maria, Alfredo Bellon, Roumen Nakov, et al.. (2019). Randomized, double-blind, cross-over phase I study comparing pharmacokinetics, pharmacodynamics, safety and immunogenicity of a biosimilar pegfilgrastim with EU and US references. Annals of Oncology. 30. v738–v738. 1 indexed citations
5.
Otto, Gordon P, Birgit Rathkolb, Christoph Lengger, et al.. (2016). Clinical Chemistry Reference Intervals for C57BL/6J, C57BL/6N, and C3HeB/FeJ Mice (Mus musculus).. PubMed. 55(4). 375–86. 90 indexed citations
6.
Chung, Ha‐Yeun, Gordon P Otto, Alexander C. Bunck, et al.. (2016). Acid Sphingomyelinase Promotes Endothelial Stress Response in Systemic Inflammation and Sepsis. Molecular Medicine. 22(1). 412–423. 30 indexed citations
7.
Otto, Gordon P, Ha‐Yeun Chung, Thomas Neumann, et al.. (2015). Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational Approach. PLoS ONE. 10(4). e0124429–e0124429. 37 indexed citations
8.
Otto, Gordon P, Barbara T. Grünwald, Christian Geis, et al.. (2015). Impact of Antibiotic Treatment Intensity on Long-Term Sepsis-Associated Kidney Injury in a Polymicrobial Peritoneal Contamination and Infection Model. ˜The œNephron journals/Nephron journals. 129(2). 137–142. 5 indexed citations
9.
Otto, Gordon P, Maik Soßdorf, Peter Schlattmann, et al.. (2014). Renal outcome after vancomycin treatment and renal replacement therapy in patients with severe sepsis and septic shock: A retrospective study. Journal of Critical Care. 29(4). 656–661. 6 indexed citations
10.
Otto, Gordon P, Maik Soßdorf, Christoph Sponholz, et al.. (2014). Impact of plasma histones in human sepsis and their contribution to cellular injury and inflammation. Critical Care. 18(5). 543–543. 175 indexed citations
11.
Soßdorf, Maik, Gordon P Otto, Katja Menge, et al.. (2013). Potential effect of physiotherapeutic treatment on mortality rate in patients with severe sepsis and septic shock: A retrospective cohort analysis. Journal of Critical Care. 28(6). 954–958. 10 indexed citations
12.
Soßdorf, Maik, Jacqueline Fischer, Stefan Meyer, et al.. (2013). Physical Exercise Induces Specific Adaptations Resulting in Reduced Organ Injury and Mortality During Severe Polymicrobial Sepsis. Critical Care Medicine. 41(10). e246–e255. 29 indexed citations
13.
Otto, Gordon P, Maik Soßdorf, Peter Recknagel, et al.. (2012). Screening for bacteremia in sepsis and renal failure using hemofilters for renal replacement therapy. Infection. 41(2). 387–390. 2 indexed citations
15.
Rey, Jean‐Marc, Oliver Schreiner, Mark Heise, et al.. (2011). Acute Renal Failure and Liver Dysfunction after Subcutaneous Injection of 3-sn-Phosphatidylcholine (Lipostabil®) - Case Report. Zeitschrift für Gastroenterologie. 49(3). 340–343. 6 indexed citations
16.
Otto, Gordon P, Maik Soßdorf, Ralf A. Claus, et al.. (2011). The late phase of sepsis is characterized by an increased microbiological burden and death rate. Critical Care. 15(4). 317 indexed citations
18.
Claus, Ralf A., Gordon P Otto, Hans‐Peter Deigner, & Michael Bauer. (2010). Approaching Clinical Reality: Markers for Monitoring Systemic Inflammation and Sepsis. Current Molecular Medicine. 10(2). 227–235. 28 indexed citations
19.
Soßdorf, Maik, Gordon P Otto, Ralf A. Claus, Holger Gabriel, & Wolfgang Lösche. (2010). Cell-Derived Microparticles Promote Coagulation after Moderate Exercise. Medicine & Science in Sports & Exercise. 43(7). 1169–1176. 63 indexed citations
20.
Soßdorf, Maik, Sascha Marx, Gordon P Otto, et al.. (2009). HES 130/0.4 impairs haemostasis and stimulates pro-inflammatory blood platelet function. Critical Care. 13(6). R208–R208. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026